AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 DEC 13 - (NewsRx.com & NewsRx.net) -- Five laboratories have signed agreements TriPath Imaging, Inc., (TPTH) to use the company's integrated cervical cytology system for the collection, preparation, staining and computerized screening of liquid-based thin-layer slides.
On October 5, 2001, the U.S. Food and Drug Administration (FDA) approved TriPath Imaging's AutoPap Primary Screening System for the screening of AutoCyte PREP thin-layer slides for screening for cancer of the uterine cervix.
In its initial rollout, TriPath Imaging has targeted strategic customers ...
Source: HighBeam Research, TriPath Imaging Announces Agreements For Integrated Cervical Cytology...